Trust Company of Vermont’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.57K Hold
14
﹤0.01% 935
2025
Q1
$3.78K Hold
14
﹤0.01% 887
2024
Q4
$3.29K Hold
14
﹤0.01% 907
2024
Q3
$3.85K Buy
+14
New +$3.85K ﹤0.01% 878
2022
Q4
Sell
-500
Closed -$100K 873
2022
Q3
$100K Buy
+500
New +$100K 0.01% 384